In summary, mRNA expression in tissue or immunohistochemistry staining of NOTCH3 from primary tumor tissue are likely to be stable predictive methods for prognosis and response to chemotherapy in patients with advanced NSCLC. Here, NOTCH3 is linked to non-small cell lung carcinoma.